Back to trial detailsIntake questionnaire
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Applying to Valkyrie Clinical Trials · Los Angeles, California
Answer a few short questions to share with the research team.
0 of 4 answered